This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Specials and orphan drugs
Specials and orphan drugs
Orphan drug committee proposes new designations
Cost of orphan drugs to EU ‘sustainable until 2020’
Shire expands pipeline to treat orphan muscle diseases through collaboration with Acceleron Pharma
Orphan status for child cancer drug
Pixantrone designated orphan drug
Pfizer licenses taliglucerase alfa
Biovitrum and Swedish Orphan will be combined forming Swedish Orphan Biovitrum
Trial boosts first ATTR-PN drug treatment
Shire reveals GBP 276m bid for Jerini
Orphan drug designation for Rhitol
Study hope for early ejaculation
Production of orphan drugs in the hospital pharmacy: the Italian experience
« Previous
1
2
3
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
3
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Pharmacy workforce: matching staffing resource to service demand
by
[email protected]
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
×
Search for: